PerkinElmer Pens Biomarker R&D Alliances With Johns Hopkins, University of Birmingham | GenomeWeb
NEW YORK (GenomeWeb News) — PerkinElmer today said it will help Johns Hopkins University and the University of Birmingham, UK, establish tools and technologies to discover diagnostic and therapeutic biomarkers in undisclosed indications.
PerkinElmer said it will use its BioExpression platform, a carrier protein-based biomarker enrichment technology that is used to find low-abundance disease-related biomarkers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.